Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation

Clin Transplant. 2009 Sep-Oct;23(5):740-7. doi: 10.1111/j.1399-0012.2009.01014.x. Epub 2009 Jun 26.

Abstract

Background: It has been reported that donor-reactive T-cell responses may decrease during the first year after HLA-mismatched organ transplantation. We wondered whether donor-reactive T-cell responses directed to minor histocompatibility antigens (mHAgs) or other non-HLA antigens also decrease after HLA-identical living-related (LR) kidney transplantation.

Methods: We studied donor-reactive T-cell responses by IFN-gamma and granzyme B (GrB) Elispot assays in 15 HLA-identical LR kidney transplant recipients before, six months and one yr after transplantation. Third-party reactivity was used as control. Patient and donor peripheral blood mononuclear cells were typed for 11 known mHAgs.

Results: During the study period, 60% and 36% of the patients demonstrated donor-reactive IFN-gamma and GrB producing cells (pc), respectively. The number of donor-reactive IFN-gamma and GrB pc was significantly lower than the number of third-party reactive IFN-gamma and GrB pc. After transplantation, donor-reactivity and third-party reactivity were comparable to pre-transplant values. No relation was found in mHAg mismatches between donor and recipient and donor-reactive T-cell response.

Conclusions: Donor-reactivity could be detected before and after HLA-identical LR kidney transplantation, but was not related with the number of mHAg mismatches, and did not decrease after transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Graft Rejection / immunology*
  • Granzymes / metabolism
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Humans
  • Interferon-gamma / metabolism
  • Kidney Transplantation / immunology*
  • Living Donors
  • Male
  • Minor Histocompatibility Antigens / immunology*
  • Postoperative Period
  • T-Lymphocytes / immunology*
  • Time Factors

Substances

  • HLA Antigens
  • Minor Histocompatibility Antigens
  • Interferon-gamma
  • GZMB protein, human
  • Granzymes